1999Pediatric Neurology BriefsOpen access

ACTH vs Vigabatrin in Infantile Spasms

J Gordon Millichap

Open full text 0 citations

Abstract

The comparative efficacy and safety of ACTH (110 IU/m2 once daily for 15 days) and vigabatrin (100-150 mg/kg/daily in bid doses) was evaluated by a retrospective analysis of medical records of 42 infants (21 in each group) with infantile spasms and hypsarrhythmia treated at the Universite de Montreal, Hopital Sainte-Justine, Montreal, Canada.

About this research paper

What this paper is about

The comparative efficacy and safety of ACTH (110 IU/m2 once daily for 15 days) and vigabatrin (100-150 mg/kg/daily in bid doses) was evaluated by a retrospective analysis of medical records of 42 infants (21 in each group) with infantile spasms and hypsarrhythmia treated at the Universite de Montreal, Hopital Sainte-Justine, Montreal, Canada.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The comparative efficacy and safety of ACTH (110 IU/m2 once daily for 15 days) and vigabatrin (100-150 mg/kg/daily in bid doses) was evaluated by a retrospective analysis of medical records of 42 infants (21 in each group) with infantile spasms and hypsarrhythmia treated at the Universite de Montreal, Hopital Sainte-Justine, Montreal, Canada.

Key concepts: Vigabatrin, Hypsarrhythmia, Medicine, Anesthesia, Medical record, Adrenocorticotropic hormone, Pediatrics, Epilepsy

Related papers

Back to paper searchBrowse research topicsOriginal source
ACTH vs Vigabatrin in Infantile Spasms — Research Paper | ScholarLens